XML 78 R58.htm IDEA: XBRL DOCUMENT v3.6.0.2
Collaborative Arrangements - Janssen Pharmaceuticals, Inc. (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                      
Royalty revenues $ 3,887 $ 3,835 $ 5,282 $ 3,596 $ 6,331 $ 5,759 $ 5,077 $ 6,792 $ 16,600 $ 23,959 $ 40,919
Collaborative revenues 937 259 675 74 5,054 1,546 611 842 1,945 8,053 51,675
Revenues $ 458,706 $ 413,783 $ 431,608 $ 398,080 $ 417,935 $ 309,816 $ 166,076 $ 138,509 1,702,177 1,032,336 580,415
Janssen                      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                      
Royalty revenues                 71 1,518 13,481
Up-front payment                     35,000
Reimbursement for research and development activities                 $ 14,700 22,800 9,100
Time period of notice required to terminate                 6 months    
Collaborative revenues                 $ (155) 1,946 7,104
Revenue, Net                 $ (84) $ 3,464 $ 20,585